Surrogate markers for liver fibrosis
Poynard, T.
Medical Journal of Malaysia 60 Suppl B: 39-40
2005
ISSN/ISBN: 0300-5283 PMID: 16108172 Document Number: 585344
Document emailed within 1 workday
Related Documents
Tsukamoto, T.; Yamamoto, T.; Ikebe, T.; Takemura, S.; Shuto, T.; Kubo, S.; Hirohashi, K.; Kinoshita, H. 2004: Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver Hepato-Gastroenterology 51(57): 777-780Iaquinto, G.; Maio, P.; Ambrosone, L.; Magliocca, M.; Taccone, W.; Imparato, L.; Rambaldi, M. 1998: Usefulness of fibrosis markers in liver diseases Italian Journal of Gastroenterology and Hepatology 30(2): 233-234
Guo, J.-X.; Ma, H.-B.; Li, Y.-L.; Xu, J.; Yang, L.-H.; Shi, J.-B.; Li, B.; Liu, A.-X.; Li, X.-X.; Li, B.-A.; Mao, Y.-L. 2009: Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(1): 71-73
Murphy, J.F.A. 2007: Surrogate markers of healthcare standards Irish Medical Journal 100(1): 324
Takashima, T.; Iijma, H.; Nishiguchi, S. 2015: Diagnosis of liver fibrosis in patients with chronic hepatitis using serum enhanced liver fibrosis (ELF) Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 145-149
Khazaeinia, T.; Jamali, F. 2000: Evaluation of gastrointestinal toxicity of ibuprofen using surrogate markers in rats: effect of formulation and route of administration Clinical and Experimental Rheumatology 18(2): 187-192
Khalifa, A.; Mady, E.A.; Abadeer, N.; Kamal, A. 1999: Differential tumor markers and hepatitis markers profile in liver tumors Anticancer Research 19(4a): 2495-2500
Volf, E.M.; Levine, D.E.; Michelon, M.A.; Au, S.-C.; Patvardhan, E.; Dumont, N.; Loo, D.S.; Kuvin, J.; Gottlieb, A.B. 2011: Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts Journal of Drugs in Dermatology: Jdd 10(8): 900-901
Okabe, K. 1992: Hepatic fibrosis and its serum markers Rinsho Byori. Japanese Journal of Clinical Pathology 40(12): 1258-1264
Fontaine, F.; Vasseur, F.; Savary, J.B.; Cousin, J.; Deminatti, M. 1986: Antenatal diagnosis of cystic fibrosis: value of DNA markers Presse Medicale 15(45): 2254
Tangkijvanich, P.; Kongtawelert, P.; Pothacharoen, P.; Mahachai, V.; Suwangool, P.; Poovorawan, Y. 2003: Serum hyaluronan: a marker of liver fibrosis in patients with chronic liver disease Asian Pacific Journal of Allergy and Immunology 21(2): 115-120
Vardar, R.; Vardar, E.; Demiri, S.; Sayhan, S.E.; Bayol, U.; Yildiz, C.şk.; Postaci, H. 2009: Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepato-Gastroenterology 56(94-95): 1459-1465
Catanzaro, R.; Sapienza, C.; Milazzo, M.; Arona, S.; Italia, A.; Samperi, L. 2013: Liver fibrosis: evaluation with diffusion-weighted magnetic resonance imaging in patients with chronic liver disease Minerva Gastroenterologica E Dietologica 59(3): 313-320
Voss, R.; Hertz, B.; Chemke, J.; Katznelson, D.; Yahav, Y. 1988: Cystic fibrosis: linked DNA markers in prenatal diagnosis and carrier detection Harefuah 114(7): 317-320
Kim, L.B.; Putiatina, A.N. 2010: Dynamics of biochemical markers of reparative fibrosis in uncomplicated course of myocardial infarction Kardiologiia 50(12): 10-14
Angelucci, E.; Baronciani, D.; Lucarelli, G.; Giardini, C.; Galimberti, M.; Polchi, P.; Martinelli, F.; Baldassarri, M.; Muretto, P. 1993: Liver iron overload and liver fibrosis in thalassemia Bone Marrow Transplantation 12(Suppl 1): 29-31
Sasaki, N.; Ueno, T.; Morita, Y.; Nagata, E.; Sata, M. 2006: Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH) Hepato-Gastroenterology 53(71): 678-681
Baiget, M.; Casals, T.; Nunes, V.; Estivill, X. 1989: Detection of carriers and prenatal diagnosis of cystic fibrosis in Spanish families using DNA markers Medicina Clinica 92(10): 361-363
Topchii, I.; Semenovykh, P.; Galchiskaya, V.; Yakymenko, Y.; Shcherban, T. 2019: Association of Fibroblast Growth Factor 23 with Markers of Inflammation and Fibrosis in Diabetic Nephropathy Georgian Medical News 2019(292-293): 44-49
Nakagawa, M.; Asahina, Y. 2015: Prognostic significance of fibrosis markers in hepatocellular carcinoma among patients with IFN-based therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 668-673